The Oncology Institute, Inc. (NASDAQ:TOI) Q3 2023 Earnings Call Transcript

Page 2 of 2

Operator: Thank you. There are no further questions at this time. I would now like to turn the floor over to Daniel for any closing comments.

Dan Virnich: Thanks so much and thank you all for joining our earnings call today. In summary, I’m very pleased with our performance in the third quarter. I’m really looking forward to wrapping up the fourth quarter of this year. Again, this past quarter we delivered strong growth year-over-year, expanded our gross margin and reduced SG&A, all of which is helping drive us towards our elimination of cash burn and path to profitability towards the end of next year. And we are seeing incredible growth opportunities in our pipeline as outlined with our new relationship we are starting in Florida and several additional opportunities, which we expect to announce in the upcoming quarters. Thank you all for joining today and that concludes my comments.

Operator: Thank you. This concludes today’s teleconference. You may disconnect your lines at this time. Thank you for your participation.

Follow Oncology Institute Inc.

Page 2 of 2